“How are you feeling?” can be an important question for men on ADT

At the upcoming meeting of the American Society for Clincial Oncology (ASCO) meeting in Chicago, Dr. Alicia Morgans of Vanderbilt University will be speaking about the physical and cognitive effects of systemic therapy in older men with prostate cancer. … READ MORE …

More on “living well” with prostate cancer

The second of our CureTalk discussions was held yesterday evening with Dr. Paul Schellhammer, Tony Crispino (the patient advocate for the Southwest Oncology Group (SWOG) Genitourinary Cancers section, and patient support group leader Paul Carpenter. … READ MORE …

Kaiser reports on quality of life outcomes after first-line treatment for prostate cancer

Kaiser Permanente maintains a large data registry in  order to assess the quality of outcomes over time among tens of thousands of Kaiser patients, prostate cancer patients included. … READ MORE …

Listen to Dr. Schellhammer discussing “Living well with prostate cancer”

Yesterday evening we were able to spend an hour talking with Dr. Paul Schellhammer — a prostate cancer patient and also a widely recognized prostate cancer specialist — about issues related to quality of life  and “living well” after diagnosis and treatment for prostate cancer over time. The recording of this conversation is now available on line on the CureTalks web site. … READ MORE …

Outcomes, side effects, quality of life, and choosing a treatment that works FOR YOU!

Three articles in this week’s Journal of the American Medical Association throw a little more light on issues related to quality of life after diagnosis and treatment for localized prostate cancer … but quite how much light it is difficult to tell. … READ MORE …

Wotz goin’ on in Canada? And wotz “True Nth”?

So apparently Prostate Cancer Canada has been working (rather secretively) on a series of projects under the umbrella name of their “True Nth” initiative. But it’s a little difficult to work out quite what is encompassed by this initiative, which has been funded (at least in part) by Movember. … READ MORE …

SBRT vs. moderate hypofractionation: same or better quality of life?

In several randomized clinical trials of external beam treatment of primary prostate cancer, we have seen that moderately hypofractionated intensity-modulated radiation therapy (HypoIMRT), accomplished in 12 to 26 treatments or fractions, is no worse than conventionally fractionated IMRT treatment (in 40 to 44 fractions). … READ MORE …